학술논문
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Source
In The Lancet 30 July-5 August 2022 400(10349):369-379
Subject
Language
ISSN
0140-6736